The latest price target for American Healthcare REIT (NYSE:AHR) was reported by Morgan Stanley on March 25, 2025. The analyst firm set a price target for $37.00 expecting AHR to rise to within 12 months (a possible 23.62% upside). 19 analyst firms have reported ratings in the last year.

The latest analyst rating for American Healthcare REIT (NYSE:AHR) was provided by Morgan Stanley, and American Healthcare REIT maintained their overweight rating.

There is no last upgrade for American Healthcare REIT

There is no last downgrade for American Healthcare REIT.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of American Healthcare REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for American Healthcare REIT was filed on March 25, 2025 so you should expect the next rating to be made available sometime around March 25, 2026.

While ratings are subjective and will change, the latest American Healthcare REIT (AHR) rating was a maintained with a price target of $36.00 to $37.00. The current price American Healthcare REIT (AHR) is trading at is $29.93, which is out of the analyst’s predicted range.